
JOINT CORP/THE
JYNTNASDAQTrading Snapshot
- Day Range
- $147.66 β $149.76
- 52-Week Range
- $7.50 β $11.26
- Volume
- $3.09B
- Avg Volume
- $2.52B
- Shares Outstanding
- 14.3M
- Next Earnings
- Oct 10, 2026
Fundamentals Snapshot
- Annual Revenue
- $55M
- Last Q Revenue
- $15M
- P/E Ratio
- 36.7
- P/S Ratio
- 2.1x
- EPS (TTM)
- $0.22
- Dividend Yield
- β
Why Investors Own JYNT
- βHigh-growth profile β revenue up +26.6% YoY with expanding US Equity exposure.
- βHealthy economics β 43% gross margin and 29% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About JOINT CORP/THE
The Joint Corp. specializes in the establishment, proprietorship, operation, and overall administration of chiropractic treatment centers. Its business operations are structured into two main divisions: corporate-owned clinics and franchised facilities. The firm employs several strategic models for its expansion and day-to-day functioning, which include direct company ownership, various management agreements, licensing its brand to franchisees, and collaborating with regional development partners. As of March 1, 2022, the company maintained approximately 700 active locations throughout the United States. Founded in 2010, The Joint Corp. maintains its primary corporate headquarters in Scottsdale, Arizona.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
JOINT CORP/THE tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift JYNT price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
JOINT CORP/THE announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.